
OMNICELL INC
OMCLNASDAQTrading Snapshot
- Day Range
- $36.42 β $37.44
- 52-Week Range
- $29.06 β $55.00
- Volume
- $2.34B
- Avg Volume
- $2.87B
- Shares Outstanding
- 45.5M
- Next Earnings
- Sep 28, 2026
Fundamentals Snapshot
- Annual Revenue
- $1.18B
- Last Q Revenue
- $312M
- P/E Ratio
- 43.3
- P/S Ratio
- 1.4x
- EPS (TTM)
- $0.85
- Dividend Yield
- β
Why Investors Own OMCL
- βHigh-growth profile β revenue up +52.7% YoY with expanding US Equity exposure.
- βHealthy economics β 54% gross margin and 30% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About OMNICELL INC
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
OMNICELL INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift OMCL price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
OMNICELL INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.